Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Su

Showing results (881-890 of 922) with videos related to

Pageof 93
Sort By:
BMC Medicine|April 22, 2024
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trialLi Xu, Jinzhang Chen, Chang Liu, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2021
Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironmentXian-Ning Wu, Dan Su, Yi-De Mei, et al.
Nature Communications|November 9, 2019
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinomaDan Su, Dadong Zhang, Jiaoyue Jin, et al.
Neoplasia (New York, N.Y.)|September 11, 2024
A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colonXiao Yang, Huichen Bai, Xi Yuan, et al.
Nucleic Acids Research|August 3, 2013
A multidimensional platform for the purification of non-coding RNA speciesYok Hian Chionh, Chia-Hua Ho, Dumnoensun Pruksakorn, et al.
Cell Reports|January 26, 2022
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2Huanhuan Zhao, Jun Lu, Tong Yan, et al.
Nature Cell Biology|February 8, 2020
BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinomaJin-Tao Li, Miao Yin, Di Wang, et al.
Cell|October 15, 2013
A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selectionJorge Zeron-Medina, Xuting Wang, Emmanouela Repapi, et al.
ACS Nano|February 6, 2023
De Novo Designed Self-Assembling Rhodamine Probe for Real-Time, Long-Term and Quantitative Live-Cell NanoscopyJie Zhang, Heng Shi, Chen Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2024
In vivo CRISPR screens identify <i>Mga</i> as an immunotherapy target in triple-negative breast cancerXu Feng, Chang Yang, Yuanjian Huang, et al.
Pageof 93

Showing results (881-890 of 922) with videos related to

Sort By:
Pageof 93
BMC Medicine|April 22, 2024
Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trialLi Xu, Jinzhang Chen, Chang Liu, et al.
Cancer Immunology, Immunotherapy : CII|March 4, 2021
Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironmentXian-Ning Wu, Dan Su, Yi-De Mei, et al.
Nature Communications|November 9, 2019
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinomaDan Su, Dadong Zhang, Jiaoyue Jin, et al.
Neoplasia (New York, N.Y.)|September 11, 2024
A highly selective PI3Kδ inhibitor BGB-10188 shows superior preclinical anti-tumor activities and decreased on-target side effects on colonXiao Yang, Huichen Bai, Xi Yuan, et al.
Nucleic Acids Research|August 3, 2013
A multidimensional platform for the purification of non-coding RNA speciesYok Hian Chionh, Chia-Hua Ho, Dumnoensun Pruksakorn, et al.
Cell Reports|January 26, 2022
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2Huanhuan Zhao, Jun Lu, Tong Yan, et al.
Nature Cell Biology|February 8, 2020
BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinomaJin-Tao Li, Miao Yin, Di Wang, et al.
Cell|October 15, 2013
A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selectionJorge Zeron-Medina, Xuting Wang, Emmanouela Repapi, et al.
ACS Nano|February 6, 2023
De Novo Designed Self-Assembling Rhodamine Probe for Real-Time, Long-Term and Quantitative Live-Cell NanoscopyJie Zhang, Heng Shi, Chen Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 19, 2024
In vivo CRISPR screens identify <i>Mga</i> as an immunotherapy target in triple-negative breast cancerXu Feng, Chang Yang, Yuanjian Huang, et al.
Pageof 93